Pleasure and discipline in the uses of Ritalin

International Journal of Drug Policy

Volumn 19, Issue 5, 2008, Pages 401-409

  Keane, Helen ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Drug use; Pharmacology; Pleasure; Ritalin

Indexed keywords

ILLICIT DRUG; METHYLPHENIDATE;

ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; AUTOREGULATION; DRUG SAFETY; DRUG USE; EMOTION; HUMAN; MEDICAL LITERATURE; PLEASURE; PRIORITY JOURNAL; PSYCHOANALYTIC THEORY; PUBLICATION; REINFORCEMENT; REWARD; SELF CONTROL; SELF DISCIPLINE; TENSION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; METHYLPHENIDATE; PLEASURE-PAIN PRINCIPLE; SUBSTANCE-RELATED DISORDERS;

EID: 51649086063     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2007.08.002     Document Type: Article

References (56)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed. (2000), American Psychiatric Association, Washington, DC
2. Barkley R.A. Attention-Deficit Hyperactivity Disorder: A handbook for diagnosis and treatment. 2nd ed. (1998), The Guildford Press, New York and London
3. Breggin P.R., and Breggin G. The hazards of treating "attention-deficit/hyperactivity disorder" with methylphenidate (Ritalin). The Journal of College Student Psychotherapy 10 2 (1995) 55-72
4. Brock D. Enhancements of human function: Some distinctions for policymakers. In: Parens E. (Ed). Enhancing human traits: Ethical and social implications (1998), Georgetown University Press, Washington, DC 30-48
5. Children, Youth and Women's Health Service. (2006) ADD and ADHD-What are they? Retrieved 17 December 2006 from http://www.cyh.com/HealthTopics/HealthTopicDetails.aspx?p=114&np=141&id=1644.
6. Coveney J., and Bunton R. In pursuit of the study of pleasure: Implications for health research and practice. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine 7 2 (2003) 161-179
7. Davis, J. (2000). Ritalin-Prescriptions don't seem to matter for some. WebMD Medical News. Retrieved 15 December 2006 from http://www.webmd.com/content/article/35/1728_57356.htm.
8. DeGrandpre R. Ritalin nation: Rapid-fire culture and the transformation of human consciousness (2000), W.W. Norton, New York
9. Derrida J. The rhetoric of drugs. An interview. Differences: A Journal of Feminist Cultural Studies 5 1 (1993) 2-25
10. Diller L. Running on Ritalin (1998), Bantam, New York
11. Duff C. Drug use as a practice of the self: Is there any place for an ethics of moderation in contemporary drug policy?. International Journal of Drug Policy 15 (2004) 385-393
12. Elliott C. Better than well: American medicine meets the American dream (2003), W.W. Norton, New York and London
13. Gomart E. Methadone: Six effects in search of a substance. Social Studies of Science 32 1 (2002) 93-135
14. Halasz G. 'Smartening up' or 'dumbing down'? A look behind the symptoms, at overprescribing and reconceptualising ADHD. In: Halasz G., et al. (Ed). Cries unheard: A new look at Attention Deficit Hyperactivity Disorder (2002), Common Ground, Alton 75-91
15. Honos-Webb L. The gift of ADHD (2005), New Harbinger, Oakland
16. Keane H. What's wrong with addiction? (2002), Melbourne University Press, Melbourne
17. Klein R.G., and Wender P. The role of methylphenidate in psychiatry. Archives of General Psychiatry 52 6 (1995) 429-433
18. Kollins S.H. Comparing the abuse potential of methylphenidate versus other stimulants: A review of available evidence and relevance to the ADHD patient. Journal of Clinical Psychiatry 64 11 (2003) 14-18
19. Kollins S.H., MacDonald E.K., and Rush C.R. Assessing the abuse potential of methylphenidate in nonhuman and human subjects. Pharmacology, Biochemistry and Behaviour 68 (2001) 611-627
20. Koob G.F., Barak C., Hyytia P., Markou A., Parsons L.H., Roberts A.J., et al. Neurobiology of drug addiction. In: Glantz M.D., and Hartel C.R. (Eds). Drug abuse: Origins and interventions (1999), American Psychological Association, Washington, DC 161-190
21. Krautkramer C. Beyond creativity: ADHD drug therapy as a moral damper on a child's future success. The American Journal of Bioethics 5 3 (2005) 52-53
22. Landry M. Understanding drugs of abuse (1994), American Psychiatric Press, Washington, DC
23. Law J. After ANT: Complexity, naming and topology. In: Law J., and Hassard J. (Eds). Actor Network Theory and after (1999), Blackwell, Oxford 2-15
24. Leshner A. Addiction is a brain disease and it matters. Science 278 5335 (1997) 45-46
25. Leshner A. Foreword. In: Glantz M.D., and Hartel C.R. (Eds). Drug abuse: Origins and interventions (1999), American Psychological Association, Washington, DC 161-190
26. Mash E.J., and Wolfe D.A. Abnormal child psychology. 2nd ed. (2002), Wadsworth, Belmont, CA
27. Miller T., and Leger M.C. A very childish moral panic: Ritalin. Journal of Medical Humanities 24 1/2 (2003) 9-33
28. Moore, D. (2006). Where did the pleasure go in drug discourses? Paper presented at Dangerous Consumptions IV colloquium, held at Australian National University in Canberra, Australia.
29. Muller J. The well-tempered learner: Self regulation, pedagogical models and teacher education policy. Comparative Education 34 2 (1998) 177-193
30. National Institute on Drug Abuse. (2006). NIDA infofacts: Methylphenidate (Ritalin). Retrieved 15 December 2006 from http://www.nida.nih.gov/pdf/infofacts/Ritalin06.pdf.
31. Office of National Drug Control Policy. (2000). Drug policy information clearinghouse fact sheet: Methadone. Retrieved 15 December 2006 from http://www.whitehousedrugpolicy.gov.
32. O'Malley P., and Mugford S. The demand for intoxicating commodities: Implications for the 'War on Drugs'. Social Justice: A Journal of Crime, Conflict, and World Order 18 (1991) 49-75
33. Pandina R.J., and Johnson V.L. Why people use, abuse and become dependent on drugs: Progress toward a heuristic model. In: Glantz M.D., and Hartel C.R. (Eds). Drug abuse: Origins and interventions (1999), American Psychological Association, Washington 119-147
34. Pfiffner L., and Barkley R. Treatment of ADHD in school settings. In: Barkley R. (Ed). Attention-Deficit Hyperactivity Disorder: A handbook for diagnosis and treatment. 2nd ed. (1998), The Guildford Press, New York and London 458-490
35. Roache J.D., Grabowski J., Schmitz J.M., Creson D.L., and Rhoades H.M. Laboratory measures of methylphenidate effects in cocaine dependent patients receiving treatment. Journal of Clinical Psychopharmacology 20 1 (2000) 61-68
36. Robinson T., and Berridge K. Addiction. Annual Review of Psychology 54 (2003) 25-53
37. Rose N. Inventing our selves: Psychology, power, and personhood (1996), Cambridge University Press, New York
38. Royal Australasian College of Physicians. (2006). Medication management for Attention Deficit Hyperactivity Disorder: A brief guide for parents and non health professionals. Retrieved 15 December 2006 from http://www.racp.edu.au/hpu/paed/ADHD_statement.pdf.
39. Safer D.J. Are stimulants overprescribed for youths with ADHD?. Annals of Clinical Psychiatry 12 1 (2000) 55-62
40. Sawyer M.G., Rey J.M., Graetz B.W., Clark J.J., and Baghurst P.A. Use of medication by young people with attention-deficit/hyperactivity disorder. The Medical Journal of Australia 177 1 (2002) 21-25
41. Schultz W. Multiple reward signals in the brain. Nature Reviews Neuroscience 1 (2000) 199-207
42. Schultz D., and Schultz S. A history of modern psychology. 4th ed. (1987), Harcourt Brace Jovanovich, San Diego
43. Schwebel R. Saying no is not enough (1989), Newmarket Press, New York
44. Shorter, E. (1997). The second biological psychiatry. In A history of psychiatry: From the era of the asylum to the age of Prozac (pp. 259-287). New York: John Wiley & Sons.
45. Singh I. Bad boys, good mothers and the 'miracle' of Ritalin. Science in Context 15 4 (2002) 577-603
46. Singh I. Will the 'real' boy please behave: Dosing dilemmas for parents of boys with ADHD. The American Journal of Bioethics 5 3 (2005) 34-47
47. Spencer T.J., Biederman J., Wilens T.E., and Faraone S.V. Overview and neurobiology of attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry 63 12 (2002) 3-9
48. Stoops W.W., Glaser P.E.A., Fillmore M.T., and Rush C.R. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. Journal of Psychopharmacology 18 4 (2004) 534-543
49. Timimi S. ADHD is best understood as a cultural construct. British Journal of Psychiatry 184 (2004) 8-9
50. Titus J. Boy trouble: Rhetorical framing of boys' underachievement. Discourse: Studies in the Cultural Politics of Education 25 2 (2004) 145-169
51. United States Department of Justice: Drug Enforcement Administration. (2006). Drugs and chemicals of concern: Methylphenidate. Retrieved 28 December 2006 from http://www.deadiversion.usdoj.gov/drugs_concern/methylphenidate.htm.
52. valentine, k., & Fraser, S. (2005). Methadone and market corrections. Paper presented at Culture-Fix: The annual conference of the Cultural Studies Association of Australasia.
53. Volkow N.D., Ding Y., Fowler J.S., Wang G., Logan J., Gatley J.S., et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Archives of General Psychiatry 52 6 (1995) 456-463
54. Werry J. Introduction. In: Werry J., and Aman M. (Eds). Practitioner's guide to psychoactive drugs for children and adolescents. 2nd ed. (1999), Plenum, New York and London 3-22
55. Wilens T.E., Faraone S.V., Biederman J., and Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111 (2003) 179-185
56. Zametkin A.J., and Ernst M. Problems in the management of attention-deficit-hyperactivity disorder. The New England Journal of Medicine 340 1 (1999) 40-46